Sort
46,585 grants matching “heart failure”
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs
$492,582Joseph C Wu · Stanford University · R01 · FY2017 · HL
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs
$492,582Joseph C Wu · Stanford University · R01 · FY2014 · HL
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs
$492,582Joseph C Wu · Stanford University · R01 · FY2016 · HL
Comparative Effectiveness of Treat-To-Target Approach versus Routine Care in Management of Gout
$492,573Seoyoung Catherine Kim · Brigham And Women'S Hospital · R01 · FY2019 · AR
Disease Status Drug Metabolism and New Drug Discovery
$492,552Irving William Wainer · National Institute On Aging · ZIA · FY2010 · AG
A dual 3D bioprinting platform for engineering a thick anisotropic myocardial tissue with geometric vasculature
$492,531Lijie Grace Zhang · George Washington University · R01 · FY2024 · HL
Understanding mitochondrial regulation of cardiac development and function through studies of Barth Syndrome
$492,523William T Pu · Boston Children'S Hospital · R01 · FY2016 · HL
Understanding mitochondrial regulation of cardiac development and function through studies of Barth Syndrome
$492,523William T Pu · Boston Children'S Hospital · R01 · FY2017 · HL
Genetic Rescue of Retinoid-Induced Dysfunction
$492,515Pilar Ruiz-Lozano · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2009 · HL
HIPPO Signaling in Pulmonary Arterial Hypertension
$492,506Elena Goncharova · University Of California At Davis · R01 · FY2022 · HL
STRESS REDUCTION AND CVD MORBIDITY AND MORTALITY IN BLACKS-II
$492,385Maharishi University Of Management · R01 · FY2005 · HL
Targeting of UnControlled Hypertension in Emergency Department (TOUCHED)
$492,324Heather Marie Prendergast · University Of Illinois At Chicago · R33 · FY2022 · HL
The Mechanistic Basis of Cyclin A2-Mediated Cardiac Repair
$492,253Hina W Chaudhry · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · HL
Endothelial dysfunction in aged Trx-deficient mice.
$492,215Kumuda C Das · Univ Of Arkansas For Med Scis · R01 · FY2011 · HL
Novel Simulation Technologies for BHV Long-Term Durability
$492,204Michael S Sacks · University Of Texas At Austin · R01 · FY2018 · HL
Determining the Driving Force for Fatigue Crack Nucleation in a Superelastic Nickel Titanium Shape Memory Alloy
$492,186John A Moore · Marquette University · · FY2019 · ENG
Engineering of Human Excitable Tissues from Unexcitable Cells
$492,077Nenad Bursac · Duke University · R01 · FY2019 · HL
HIPPO Signaling in Pulmonary Arterial Hypertension
$492,072Elena Goncharova · University Of California At Davis · R01 · FY2023 · HL
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition
$492,044Nancy Joan Brown · Yale University · R01 · FY2022 · HL
Imaging Signaling Changes in Cancer and Treatment
$492,028Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA
Role of cGAS-STING in cardiomyocyte cell cycle regulation
$492,000Hesham Sadek · Ut Southwestern Medical Center · P01 · FY2023 · HL
Targeting of Apoptotic and Autophagy Pathways for Treatment of Pulmonary Arterial Hypertension (PAH)
$492,000Vivek Gupta · St. John'S University · R15 · FY2018 · HL
The Role of PARP-SIR2 Signaling in Heart Failure
$491,959Mahesh P Gupta · University Of Chicago · R01 · FY2010 · HL
Proteome and Transcriptome Markers of Hypertension in Urine and Plasma Exosomes
$491,956Kevin L Schey · Vanderbilt University · RC1 · FY2010 · HL
Characterization and targeting of leukemia stem cell metabolism
$491,936Craig T. Jordan · University Of Colorado Denver · R01 · FY2020 · CA